| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
protection of telomeres 1 | 0.560 | 0.731 | 0.85 |
|
disease | 0.400 | None | 1.000 | 2 | 1 | 2013 | 2014 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.370 | None | 1.000 | 7 | 0 | 1988 | 1998 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.320 | None | 1.000 | 7 | 0 | 1997 | 2011 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
disease | 0.310 | None | 0.500 | 2 | 0 | 1999 | 2014 | ||||||||
|
immunoglobulin heavy variable 3-21 | 0.780 | 0.192 |
|
disease | 0.300 | None | 1.000 | 4 | 0 | 2011 | 2013 | |||||||||
|
ribosomal protein S15 | 0.695 | 0.231 | 0.83 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2015 | 2016 | ||||||||
|
IKAROS family zinc finger 3 | 0.608 | 0.692 | 0.98 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
ADP ribosylation factor like GTPase 11 | 0.670 | 0.423 | 5.3E-03 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
purinergic receptor P2X 7 | 0.450 | 0.808 | 3.3E-11 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
immunoglobulin heavy constant gamma 1 (G1m marker) | 0.700 | 0.500 |
|
disease | 0.300 | None | 0 | 0 | ||||||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.150 | None | 1.000 | 7 | 3 | 1991 | 2016 | ||||||||
|
interferon regulatory factor 4 | 0.491 | 0.769 | 0.86 |
|
disease | 0.110 | None | 0.833 | 6 | 2 | 2000 | 2016 | ||||||||
|
lymphoid enhancer binding factor 1 | 0.486 | 0.769 | 1.00 |
|
disease | 0.110 | None | 1.000 | 4 | 3 | 2013 | 2017 | ||||||||
|
deleted in lymphocytic leukemia 1 | 0.569 | 0.692 | 0.47 |
|
disease | 0.110 | None | 1.000 | 2 | 1 | 1989 | 2019 | ||||||||
|
GRAM domain containing 1B | 0.736 | 0.385 | 1.00 |
|
disease | 0.100 | None | 1.000 | 7 | 4 | 2008 | 2017 | ||||||||
|
acyl-CoA oxidase like | 0.674 | 0.577 | 5.2E-15 |
|
disease | 0.100 | None | 1.000 | 7 | 5 | 2008 | 2017 | ||||||||
|
MIR4435-2 host gene | 0.604 | 0.692 |
|
disease | 0.100 | None | 1.000 | 7 | 5 | 2008 | 2017 | |||||||||
|
downregulated RNA in cancer, inhibitor of cell invasion and migration | 0.736 | 0.423 |
|
disease | 0.100 | None | 1.000 | 6 | 3 | 2008 | 2017 | |||||||||
|
SP140 nuclear body protein | 0.691 | 0.577 | 5.0E-08 |
|
disease | 0.100 | None | 1.000 | 6 | 3 | 2008 | 2017 | ||||||||
|
BCL2 antagonist/killer 1 | 0.555 | 0.769 | 7.4E-06 |
|
disease | 0.100 | None | 1.000 | 4 | 2 | 2012 | 2017 | ||||||||
|
gametogenetin binding protein 1 (pseudogene) | 0.769 | 0.462 | 0.69 |
|
disease | 0.100 | None | 1.000 | 4 | 2 | 2012 | 2017 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
disease | 0.100 | None | 1.000 | 3 | 3 | 2013 | 2017 | ||||||||
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
disease | 0.100 | None | 1.000 | 3 | 3 | 2013 | 2017 | |||||||||
|
cancer susceptibility 19 | 0.769 | 0.423 |
|
disease | 0.100 | None | 1.000 | 3 | 3 | 2013 | 2017 | |||||||||
|
chromosome 11 open reading frame 21 | 0.821 | 0.192 | 1.6E-02 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2017 |